ES8206975A1 - Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x. - Google Patents

Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x.

Info

Publication number
ES8206975A1
ES8206975A1 ES507400A ES507400A ES8206975A1 ES 8206975 A1 ES8206975 A1 ES 8206975A1 ES 507400 A ES507400 A ES 507400A ES 507400 A ES507400 A ES 507400A ES 8206975 A1 ES8206975 A1 ES 8206975A1
Authority
ES
Spain
Prior art keywords
sange
preparation
procedure
production
coagulation factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES507400A
Other languages
English (en)
Spanish (es)
Other versions
ES507400A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES507400A0 publication Critical patent/ES507400A0/es
Publication of ES8206975A1 publication Critical patent/ES8206975A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES507400A 1980-11-29 1981-11-24 Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x. Expired ES8206975A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803045153 DE3045153A1 (de) 1980-11-29 1980-11-29 Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x

Publications (2)

Publication Number Publication Date
ES507400A0 ES507400A0 (es) 1982-09-01
ES8206975A1 true ES8206975A1 (es) 1982-09-01

Family

ID=6117972

Family Applications (1)

Application Number Title Priority Date Filing Date
ES507400A Expired ES8206975A1 (es) 1980-11-29 1981-11-24 Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x.

Country Status (10)

Country Link
US (1) US4405603A (enExample)
EP (1) EP0053338B1 (enExample)
JP (1) JPS57120524A (enExample)
AT (1) ATE11640T1 (enExample)
AU (1) AU544157B2 (enExample)
CA (1) CA1182047A (enExample)
DE (2) DE3045153A1 (enExample)
ES (1) ES8206975A1 (enExample)
IL (1) IL64396A (enExample)
MX (1) MX6947E (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
EP0124506B1 (de) * 1983-05-02 1988-08-17 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Inaktivierung von vermehrungsfähigen Krankheitserregern
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
JPS6094917A (ja) * 1983-10-28 1985-05-28 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
US4490361A (en) * 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US5171569A (en) * 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
WO1989005652A1 (en) * 1987-12-21 1989-06-29 American National Red Cross Pure factor ix product
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
FR2664165B1 (fr) * 1990-07-03 1992-10-16 Lille Transfusion Sanguine Composition pour stabiliser le plasma sanguin en cours de pasteurisation.
CA2105282C (en) 1991-03-01 2002-09-24 Centeon L.L.C. Preparation of factor ix
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
FR2687317B1 (fr) * 1992-02-13 1995-06-23 Aetsrn Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4342132C1 (de) 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
US6372716B1 (en) * 1994-04-26 2002-04-16 Genetics Institute, Inc. Formulations for factor IX
US5770700A (en) * 1996-01-25 1998-06-23 Genetics Institute, Inc. Liquid factor IX formulations
EP1010852A1 (en) 1998-12-15 2000-06-21 Schlegel BVBA Sealing gasket and method of making and inserting the same
GB0521139D0 (en) 2005-10-18 2005-11-23 Univ Sheffield Therapeutic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081432A (en) * 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human

Also Published As

Publication number Publication date
IL64396A (en) 1985-02-28
EP0053338B1 (de) 1985-02-06
JPS57120524A (en) 1982-07-27
ES507400A0 (es) 1982-09-01
US4405603A (en) 1983-09-20
AU7795081A (en) 1982-06-10
DE3045153A1 (de) 1982-07-08
MX6947E (es) 1986-12-19
AU544157B2 (en) 1985-05-16
EP0053338A3 (en) 1982-08-04
IL64396A0 (en) 1982-02-28
CA1182047A (en) 1985-02-05
JPH0348171B2 (enExample) 1991-07-23
ATE11640T1 (de) 1985-02-15
DE3168834D1 (en) 1985-03-21
EP0053338A2 (de) 1982-06-09

Similar Documents

Publication Publication Date Title
ES8206975A1 (es) Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x.
ES8305213A1 (es) Procedimiento para produccion de un preparado a base de protombina y-o procomuertina.
ES502298A0 (es) Metodo de producir dispersiones polimericas acuosas estables
DK158474C (da) Fremgangsmaade til fremstilling af vaevsthromboplastinpraeparat og reagens indeholdende vaevsthromboplastinpraeparatet
DE3173537D1 (en) Permselective fluoropolymeric membrane and method of its production
JPS5450196A (en) Method of dialyzing blood in artificial kidney
ATA224081A (de) Vorrichtung zur erzeugung von rillen in filterst[bchen
AU5405790A (en) Electrodialytic water splitting process for the treatment of aqueous electrolytes
FI900460A0 (fi) Bipolaariset tarkkuusmembraanit, niiden valmistusmenetelmä ja käyttö
ATA248977A (de) Verfahren zur herstellung von alsblutplasmaexpander geeigneter hydroxyaethylstaerke
ES501389A0 (es) Procedimiento para la preparacion de soluciones concentradasde cromogenos
DE3867745D1 (de) Verfahren zur herstellung von aromatischen aldehyden.
AU514402B2 (en) S. p. membrane fractionation of vegetal acid hydrolysate
ATA535377A (de) Verfahren zur herstellung von homo- und copolymerisaten von c2- bis c6-alpha-mono- olefinen
ES505483A0 (es) Procedimiento para la concentracion de soluciones acuosas deglicoles
ATE8986T1 (de) Verfahren zur herstellung von formaldehyd.
JPS57102814A (en) Tablet
ES450053A1 (es) Un procedimiento para elaborar un producto de proteina tex- turizada.
DK398680A (da) Fremgangsmaade til fremstilling af en vandig oploesning af calciumnitrit
GR63591B (en) Method for preparation of an homogeneous calcium aqueous solution
PL268092A1 (en) Method of obtaining aqueous solutions of n,n,n-trihydroxyethyl-n-stearylmethylenediamine hydrofluoride as well as of its mixture with oleilamine hydrofluoride
DK440088D0 (da) Fremgangsmaade til fremstilling af n6-benzyloxycarbonyl-2,6-diaminopimelamsyre
MX5945E (es) Procedimiento mejorado para la recuperacion de cefaloridina de soluciones acuosas en las cuales se produce
AT362983B (de) Verfahren zur herstellung von waessrigen stabilen genussaeureloesungen
ATA871078A (de) Verfahren zur herstellung detoxifizierter zubereitungen von cytostatika

Legal Events

Date Code Title Description
PC1A Transfer granted